رجوع
نطاق اليوم
KWD 0.11
KWD 0.11
نطاق 52 أسبوعًا
KWD 0.05
KWD 0.11
حجم التداول
15,000
متوسط 50 يوم / 200 يوم
KWD 0.11
/
KWD 0.10
الإغلاق السابق
KWD 0.11
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.2 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -72.9 | 3.9 |
| Rev Growth 5Y % | -2.7 | 10.0 |
| D/E | — | 0.2 |
النقاط الرئيسية
Revenue declined -2.71% annually over 5 years
Negative free cash flow of -43.90M
PEG of 0.25 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 39.60%
Capital efficient — spends only 5.93% of revenue on capex
النمو
Revenue Growth (5Y)
-2.71%
Revenue (1Y)36.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC-98.76%
Net Margin-72.91%
Op. Margin-37.27%
الأمان
Debt / Equity
N/A
Current Ratio0.93
Interest Coverage-4.21
التقييم
P/E Ratio
-9.16
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.89% | Revenue Growth (3Y) | 12.61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2.71% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 75.56M | Net Income (TTM) | -55.09M |
| ROE | N/A | ROA | -81.57% |
| Gross Margin | 45.65% | Operating Margin | -37.27% |
| Net Margin | -72.91% | Free Cash Flow (TTM) | -43.90M |
| ROIC | -98.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.93 |
| Interest Coverage | -4.21 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.16 | P/B Ratio | N/A |
| P/S Ratio | 6.68 | PEG Ratio | 0.25 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 504.57M | Enterprise Value | 547.10M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75.56M | 55.20M | 59.59M | 72.77M | 84.33M |
| Net Income | -55.09M | -40.22M | -43.07M | -13.78M | 2.89M |
| EPS (Diluted) | -0.01 | -0.01 | -0.04 | -0.01 | 0.00 |
| Gross Profit | 34.50M | 29.74M | 33.25M | 49.51M | 62.23M |
| Operating Income | -28.16M | -35.26M | -39.65M | -12.25M | 4.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 67.54M | 64.83M | 66.77M | 73.58M | 88.09M |
| Total Liabilities | 131.43M | 61.12M | 64.70M | 35.18M | 39.55M |
| Shareholders' Equity | -38.70M | 3.71M | 2.07M | 37.77M | 48.54M |
| Total Debt | 60.09M | 30.99M | 35.99M | 10.53M | 11.17M |
| Cash & Equivalents | 17.56M | 12.72M | 14.65M | 20.52M | 40.27M |
| Current Assets | 34.68M | 33.48M | 33.53M | 42.39M | 57.86M |
| Current Liabilities | 37.33M | 20.55M | 18.57M | 17.80M | 18.23M |